Skip to content
Loop Biz – Lifestyle
Author:
Tris Pharma, Inc.
Tris Pharma Announces Positive Debut Data from Phase 3 ALLEVIATE-1 and 2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting
March 6, 2026